[96a5a0]: / output / allTrials / identified / NCT02788565_identified.json

Download this file

157 lines (157 with data), 6.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
{
"info": {
"nct_id": "NCT02788565",
"official_title": "SOMATOSTATIN TREATMENT EXPERIENCE TRIAL An Observational Cross Sectional Trial Investigating Quality of Life, Treatment Experience and Direct Cost of Treatment With Somatostatin Analogues in Subjects With Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS)",
"inclusion_criteria": "* Signed informed consent\n* Diagnosed with a Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) and treated with SSA for at least three months but not more than 3 years\n* GEP-NET proliferation index Ki 67 <10%\n* Over 18 years of age\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* No specific exclusion criteria defined",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Signed informed consent",
"criterions": [
{
"exact_snippets": "Signed informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "* Diagnosed with a Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) and treated with SSA for at least three months but not more than 3 years",
"criterions": [
{
"exact_snippets": "Diagnosed with a Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)",
"criterion": "Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "treated with SSA for at least three months but not more than 3 years",
"criterion": "SSA treatment duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 3,
"unit": "months"
},
{
"operator": "<=",
"value": 3,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* GEP-NET proliferation index Ki 67 <10%",
"criterions": [
{
"exact_snippets": "GEP-NET proliferation index Ki 67 <10%",
"criterion": "GEP-NET proliferation index Ki 67",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 10,
"unit": "%"
}
}
]
}
]
},
{
"line": "* Over 18 years of age",
"criterions": [
{
"exact_snippets": "Over 18 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* No specific exclusion criteria defined",
"criterions": [
{
"exact_snippets": "No specific exclusion criteria defined",
"criterion": "exclusion criteria",
"requirements": [
{
"requirement_type": "definition",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}